October 28, 2010
BY Erin Krueger
Bolingbrook, Ill.-based Elevance Renewable Sciences Inc. has entered into a joint development agreement with Northfield, Ill.-based Stepan Co. to evaluate and commercialize novel surfactants, antimicrobials and polyurethane polyols. The materials, which will be manufactured using Elevance’s 9-decenoic ester and C18 di-basic ester specialty feedstocks, are intended for use in a wide variety of applications in the consumer, institutional, industrial and surfactant markets.
"What we are doing is taking advantage of complementary capabilities for both companies," said Andy Shafer, Elevance’s executive vice president of sales and market development. Elevance will manufacture new derivatives of renewable oils at its future biorefinery in Indonesia using its proprietary technology process. The commercial-scale plant is currently under construction and expected to begin operations during the second half of 2011, Shafer said, adding that the derivatives to be produced at the facility are exceptional building blocks for the targeted applications.
In turn, Stepan has a wide range of chemical processes to create end-use products out of those derivatives to serve customers in the surfactant, antimicrobial and polyurethane markets. "Stepan envisions utilizing our global network of existing manufacturing sites to bring these future products to the market," said Scott Behrens, Stepan’s vice president of business management. "As part of this, our recently expanded operations in Asia would be considered a future targeted production region for surfactants, antimicrobials and polyols commercialized from this technology."
Advertisement
Advertisement
"We’re combining those capabilities," Shafer said, noting that Stepan also has knowledge and access of downstream markets and customers. "By putting that all together, we think we’ll be able to serve the market with some new products that have enhanced performance benefits."
Advertisement
Advertisement